197 related articles for article (PubMed ID: 4198609)
21. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
Parodi FA
Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
[No Abstract] [Full Text] [Related]
22. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
23. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
[No Abstract] [Full Text] [Related]
24. A new antidiabetic agent.
Gupta SD; Mukerjee AB
J Indian Med Assoc; 1974 Dec; 63(11):357-9. PubMed ID: 4282091
[No Abstract] [Full Text] [Related]
25. Effect of glipizide on a double-meal test in diabetic patients.
Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
[No Abstract] [Full Text] [Related]
26. [Clinical trial of glypizide].
Cañadell Vidal J
Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
[No Abstract] [Full Text] [Related]
27. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Pou Torelló JM; Vilaclara JM
Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
[No Abstract] [Full Text] [Related]
28. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
Forattini C
Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
[No Abstract] [Full Text] [Related]
29. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
30. [Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus].
Guillon J; Charbonnel B
Cah Med; 1972 Nov; 13(14):999-1006. PubMed ID: 4646244
[No Abstract] [Full Text] [Related]
31. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
Ninni M; Castelletta L
Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
[No Abstract] [Full Text] [Related]
32. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
Lentini S; Bossini A; Pirola LC
Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
[No Abstract] [Full Text] [Related]
33. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
Emanueli A; Molari E; Pirola LC; Caputo G
Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
[No Abstract] [Full Text] [Related]
34. [Oral antidiabetics].
Bäbler M
Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
[No Abstract] [Full Text] [Related]
35. [Treatment of diabetes mellitus with glibornurid].
Vignati E; Liuzzi A; Chiodini PG
Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
[No Abstract] [Full Text] [Related]
36. [Treatment of diabetes with low doses of glypizide].
Lozano-Castañeda O; Schulte J; Gonzálex Barranco J; García Viveros M; Rull JA
Prensa Med Mex; 1974; 39(7-8):358-61. PubMed ID: 4453534
[No Abstract] [Full Text] [Related]
37. Insulin and oral hypoglycemic agents.
Price MJ
Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
[No Abstract] [Full Text] [Related]
38. [Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds].
Grujić M; Rizvanbegović B; Perinović M; Perinović ID
Med Arh; 1976; 30(2):119-21. PubMed ID: 971371
[No Abstract] [Full Text] [Related]
39. [Progress in oral antidiabetic therapy].
Rambert P
Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034
[No Abstract] [Full Text] [Related]
40. [First experiences with the sulfonylurea derivative glibornuride in diabetes therapy].
Wolfram G; Dörfler H; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():552-4. PubMed ID: 5005531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
